Albrecht H - Search Results

1

Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines.

Kübler E, Albrecht H. Kübler E, et al. Among authors: albrecht h. Oncotarget. 2018 May 18;9(38):24882-24897. doi: 10.18632/oncotarget.25427. eCollection 2018 May 18. Oncotarget. 2018. PMID: 29861840 Free PMC article.

2

Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells.

Li P, Diab S, Yu M, Adams J, Islam S, Basnet SK, Albrecht H, Milne R, Wang S. Li P, et al. Among authors: albrecht h. Oncotarget. 2016 Aug 30;7(35):56811-56825. doi: 10.18632/oncotarget.10796. Oncotarget. 2016. PMID: 27462781 Free PMC article.

3

Systematic Meta-Analysis Identifies Co-Expressed Kinases and GPCRs in Ovarian Cancer Tissues Revealing a Potential for Targeted Kinase Inhibitor Delivery.

Albrecht H, Kübler E. Albrecht H, et al. Pharmaceutics. 2019 Sep 2;11(9):454. doi: 10.3390/pharmaceutics11090454. Pharmaceutics. 2019. PMID: 31480803 Free PMC article.

4

Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines.

Khetan R, Dharmayanti C, Gillam TA, Kübler E, Klingler-Hoffmann M, Ricciardelli C, Oehler MK, Blencowe A, Garg S, Albrecht H. Khetan R, et al. Among authors: albrecht h. Cancers (Basel). 2022 May 10;14(10):2362. doi: 10.3390/cancers14102362. Cancers (Basel). 2022. PMID: 35625966 Free PMC article. Review.

5

Targeting prostate cancer cells with genetically engineered polypeptide-based micelles displaying gastrin-releasing peptide.

Zhang W, Garg S, Eldi P, Zhou FH, Johnson IR, Brooks DA, Lam F, Rychkov G, Hayball J, Albrecht H. Zhang W, et al. Among authors: albrecht h. Int J Pharm. 2016 Nov 20;513(1-2):270-279. doi: 10.1016/j.ijpharm.2016.09.039. Epub 2016 Sep 12. Int J Pharm. 2016. PMID: 27633281

6

Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles.

Zhang W, Song Y, Eldi P, Guo X, Hayball JD, Garg S, Albrecht H. Zhang W, et al. Among authors: albrecht h. Int J Nanomedicine. 2018 Jan 9;13:293-305. doi: 10.2147/IJN.S152485. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29391790 Free PMC article.

7

Discovery of 5-(2-(phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one derivatives as potent Mnk2 inhibitors: synthesis, SAR analysis and biological evaluation.

Diab S, Teo T, Kumarasiri M, Li P, Yu M, Lam F, Basnet SK, Sykes MJ, Albrecht H, Milne R, Wang S. Diab S, et al. Among authors: albrecht h. ChemMedChem. 2014 May;9(5):962-72. doi: 10.1002/cmdc.201300552. Epub 2014 Feb 12. ChemMedChem. 2014. PMID: 24677692

8

Targeting CDK9: a promising therapeutic opportunity in prostate cancer.

Rahaman MH, Kumarasiri M, Mekonnen LB, Yu M, Diab S, Albrecht H, Milne RW, Wang S. Rahaman MH, et al. Among authors: albrecht h. Endocr Relat Cancer. 2016 Dec;23(12):T211-T226. doi: 10.1530/ERC-16-0299. Epub 2016 Aug 31. Endocr Relat Cancer. 2016. PMID: 27582311 Review.

9

In Search of Novel CDK8 Inhibitors by Virtual Screening.

Kumarasiri M, Teo T, Yu M, Philip S, Basnet SK, Albrecht H, Sykes MJ, Wang P, Wang S. Kumarasiri M, et al. Among authors: albrecht h. J Chem Inf Model. 2017 Mar 27;57(3):413-416. doi: 10.1021/acs.jcim.6b00711. Epub 2017 Feb 16. J Chem Inf Model. 2017. PMID: 28191946

10

Discovery of CDK5 Inhibitors through Structure-Guided Approach.

Khair NZ, Lenjisa JL, Tadesse S, Kumarasiri M, Basnet SKC, Mekonnen LB, Li M, Diab S, Sykes MJ, Albrecht H, Milne R, Wang S. Khair NZ, et al. Among authors: albrecht h. ACS Med Chem Lett. 2019 Mar 20;10(5):786-791. doi: 10.1021/acsmedchemlett.9b00029. eCollection 2019 May 9. ACS Med Chem Lett. 2019. PMID: 31098000 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

578 results

Search Page